Finzati - Logo
NNVC logo

NanoViricides, Inc.

NNVCBiotechnology
$1.12
-0.03 (-3.03%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$29.21M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:15 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.12
Change-3.03%
Market Cap$29.21M
52W Range0.85 - 2.23
Beta1.69
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1.28
Quick Ratio1.28
Volume301.91K

Investment DNA

How strong this company looks for long-term investors

43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score
Manageable debt level · 0Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/26/2005
Industry: Biotechnology
P/B i: 2.82
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.00
Current Ratio: 1.28
Quick Ratio: 1.28
Status: Moderate

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
BONIUK MILTON
Transaction: 02/21/2017
OTHER
Change
0
Price
Not reported
Filing
01/28/2025
Type
OTHER
Stephenson Fournier, PLLC
Transaction: 02/21/2017
OTHER
Change
0
Price
Not reported
Filing
01/24/2025
Type
OTHER
Diwan Anil
Transaction: 08/08/2022
SELL
Change
-94,471
Price
Not reported
Filing
08/10/2022
Type
SELL